Hottub News

2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma

1 report from 1 outlet in 1 language · first reported · updated · JSON

HealthInnovent

Reports

  1. 2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myelomaprnewswire.com · en ·

More in Health

  1. Doctors warn about the risks energy drinks pose to kids. What families need to know75 outlets
  2. Lilly's EloraTZP tops Zepbound in mid-stage obesity trial49 outlets
  3. Home Bargains shoppers warned not to eat 2 items as urgent recall issued40 outlets
  4. Florida's dengue outbreak reportedly largest US has seen in decades26 outlets
  5. Alison Hammond provides health update after clutching chest on live television32 outlets
  6. After Covid: Life expectancy has almost recovered24 outlets